Influence of fluoxetine on regional serotonin synthesis in the rat brain

Journal of Neurochemistry

Volumn 67, Issue 6, 1996, Pages 2434-2442

  Mück Šeler, Dorotea ^a   Jevric Causevic, Adlija ^a   Diksic, Mirko ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Acute fluoxetine; Chronic fluoxetine; Serotonin synthesis; Tryptophan hydroxylase

Indexed keywords

FLUOXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BINDING AFFINITY; BINDING SITE; BRAIN METABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 0029851995     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67062434.x     Document Type: Article

References (45)

1. Auerbach S. B., Minzenberg M. J., and Wilkinson L. O. (1989) Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 499, 281-290.
2. Badawy A. A.-B., Morgan C. J., Bano S., Buckland P., and McGuffin P. (1996) Mechanism of enhancement of rat brain serotonin synthesis by acute fluoxetine administration. J. Neurochem. 66, 436-437.
3. Baldessarini R. J., Marsh E. R., and Kula N. S. (1992) Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions. Brain Res. 579, 152-156.
4. Bano S., Toor M., Morgan C. J., Badawy A. A.-B., Buckland P., and McGuffin P. (1995) Inhibition of rat liver tryptophan pyrrolase activity by acamprosate, moclobemide, roxindole, SSRI's and tianeptine. J. Psychopharmacol. 9(Suppl.), A23.
5. Bel N. and Artigas F. (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15, 243-245.
6. Benfield P., Heel R. C., and Lewis S. P. (1986) Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 32, 481-508.
7. Bevington P. R. (1969) Data Reduction and Error Analysis for the Physical Sciences. McGraw-Hill, New York.
8. Blandina P., Goldfarb J., Craddock-Royal B., and Green P. J. (1989) Release of endogenous dopamine by stimulation of 5-hydroxytryptamine-3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251, 803-809.
9. Byerly W. P. and Risch C. (1985) Depression and serotonin metabolism rationale neurotransmitter precursor treatment. J. Clin. Psychopharmacol. 5, 191-206.
10. Cusack B., Nelson A., and Richelson E. (1994) Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl.) 114, 559-565.
11. Dailey J. W., Yan Q. S., Mishra P. K., Burger R. L., and Jobe P. C. (1992) Effects of fluoxetine on convulsion and on brain serotonin as detected by microdialysis in genetically epilepsyprone rats. J. Pharmacol. Exp. Ther. 260, 533-540.
12. Diksic M., Nagahiro S., Sourkes T. L., and Yamamoto Y. L. (1990) A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. J. Cereb. Blood Flow Metab. 10, 1-12.
13. Diksic M., Nagahiro S., Chaly T., Sourkes T. L., Yamamoto Y. L., and Feindel W. (1991) Serotonin synthesis rate measured in living dog brain by positron emission tomography. J. Neurochem. 56, 153-162.
14. Diksic M., Nagahiro S., and Grdiša M. (1995) The regional rate of serotonin synthesis estimated by the α-methyl-tryptophan method in rat brain from one-time method. J. Cereb. Blood Flow Metab. 15, 806-813.
15. 3 receptor-mediated current by the selective serotonin uptake inhibitor, fluoxetine. Neurosci. Lett. 173, 210-212.
16. Fowler C. J. and Tipton K. F. (1982) Deamination of serotonin by both forms of monoamine oxidase in the rat brain. J. Neurochem. 38, 733-736.
17. Fuller R. W. and Wong D. T. (1987) Serotonin reuptake blockers in vitro and in vivo. J. Clin. Psychopharmacol. 7(Suppl.), 36S-43S.
18. Fuller R. W., Wong D. T., and Robertson D. W. (1991) Fluoxetine, a selective inhibitor of serotonin uptake. Med. Res. Rev. 11, 17-34.
19. Garrick N. A. and Murphy D. L. (1982) Monoamine oxidase type A: differences in selectivity towards L-norepinephrine compared to serotonin. Biochem. Pharmacol. 31, 4061-4066.
20. Guan X. M. and McBride W. J. (1988) Fluoxetine increases the extracellular levels of serotonin in nucleus accumbens. Brain Res. Bull. 21, 43-46.
21. 3H]-imipramine recognition sites in rat brain by chronic treatment with antidepressants. Eur. J. Pharmacol. 138, 159-168.
22. 2 sites in cortex and amygdala. Brain Res. 614, 37-44.
23. Hwang E. C., Magnussen I., and Van Woert M. H. (1980) Effects of chronic fluoxetine on serotonin metabolism. Res. Commun. Chem. Pathol. Pharmacol. 29, 79-98.
24. Johansen P., Wolf W. A., and Kuhn D. M. (1991) Inhibition of tryptophan hydroxylase by benserazide and other catechols. Biochem. Pharmacol. 41, 625-628.
25. Joyce J. N. (1993) The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology (Berl.) 112, 516-534.
26. Kokotos Leonardi E. T. and Azmitia E. C. (1994) MDMA (Ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology 10, 231-238.
27. Long J. B., Youngblood W. Y., and Kizer J. S. (1983) Regional differences in the response of serotoninergic neurons in rat CNS to drugs. Eur. J. Pharmacol. 88, 89-97.
28. Mück-Šeler D. and Diksic M. (1994) The acute effects of NSD-1015 and pargyline on the brain 5-HT synthesis rate measured by the autoradiographic method (Abstr. 170), in Proceedings of the Third IUPHAR Satellite Meeting on Serotonin. IUPHAR, Chicago.
29. Mück-Šeler D. and Diksic M. (1995) The acute effects of reserpine and NSD-1015 on the brain 5-HT synthesis rate measured by the autoradiographic method. Neuropsychopharmacology 12, 251-262.
30. 14C] methyl-L-tryptophan. Appl. Radiat, Isot. 44, 1167-1172.
31. Nagahiro S., Takada A., Diksic M., Sourkes T. L., Missala K., and Yamamoto Y. L. (1990) A new method to measure brain serotonin synthesis in vivo. II. A practical autoradiographic method tested in normal and lithium-treated rats. J. Cereb. Blood Flow Metab. 10, 13-21.
32. Perry K. W. and Fuller R. W. (1992) Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci. 50, 1683-1690.
33. Rutter J. J., Gundlah C., and Auerbach S. B. (1994) Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci. Lett. 171, 183-186.
34. Samanin R. and Garattini S. (1990) The pharmacology of serotoninergic drugs affecting appetite, in Nutrition and the Brain, Vol. 8 (Wurtman R. J. and Wurtman J. J., eds ), pp. 163-192. Raven Press, New York.
35. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897-916.
36. Sourkes T. L. (1974) Effect of α-methyltryptophan on tryptophan, 5-hydroxytryptamine and protein metabolism in the brain, in Ciba Foundation Symposium22 (New Series): Aromatic Amino Acids in the Brain, pp. 361-378.
37. Takada A., Grdisw̌a M., Diksic M., Gjedde A., and Yamamoto Y. L. (1993) Rapid steady-state analysis of blood-brain transfer of L-Trp in rat, with special reference to the plasma protein binding. Neurochem. Int. 23, 351-359.
38. Trouvin J. H., Gardier A. M., Chanut E., Pages N., and Jocquot C. (1993) Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat. Life Sci 52, 187-192.
39. Tsuiki K., Yamamoto Y. L., and Diksic M. (1995) Effect of acute fluoxetine treatment on the brain serotonin synthesis as measured by the α-methyl-L-tryptophan autoradiographic method. J. Neurochem. 65, 250-256.
40. Vanier M., Tsuiki K., Grdiǎa M., Worsley K., and Diksic M. (1995) Determination of the lumped constant for the α-methyl-tryptophan method of estimating the rate of serotonin synthesis. J. Neurochem. 64, 624-635.
41. Waldmeier P. C. (1985) Displacement of striatal 5-hydroxytryptamine by dopamine released from endogenous stores. J. Pharm. Pharmacol. 37, 58-60.
42. Wolf W. A., Youdim M. B. H., and Kuhn D. M. (1985) Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity? Eur. J. Pharmacol. 109, 381-387.
43. Wong D. T., Bymaster F. P., Reid L. R., and Threlkeld P. G. (1983) Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Biochem. Pharmacol. 32, 1287-1293.
44. Wong D. T., Reid L. R., Bymaster F. P., and Threlkeld P. G. (1985) Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors. J. Neural Transm. 64, 251-269.
45. Wong D. T., Threlkeld P. G., and Robertson D. W. (1991) Affinities of fluoxetine, its enantiomers and other inhibitors of serotonin uptake for subtypes of serotonin receptors. Neuropsychopharmacology 5, 43-47.